A REVIEW OF CONOLIDINE

These final results, along with a past report exhibiting that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two assist the idea of targeting ACKR3 as a unique solution to modulate the opioid program, which could open up new therapeutic avenues for opioid-connected disorders.A analysis review posted in Anesthesiology